Oxaliplatin Qilu Pharma Spain

Oxaliplatin, the active ingredient in Oxaliplatin Qilu Pharma Spain, is a platinum compound presented as a sterile injectable solution for intravenous use. It is employed in the treatment of colorectal cancer and related solid tumours in adult patients. GNH USA supplies Oxaliplatin Qilu Pharma Spain as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres, hospitals and pharmacies worldwide.

GNH USA supplies Oxaliplatin Qilu Pharma Spain as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres, hospitals and pharmacies worldwide.

Oxaliplatin is used primarily for colorectal cancer treatment pathways.

- Metastatic colorectal cancer: Enhances the efficacy of combination chemotherapy regimens. - Adjuvant therapy for stage II‑III colorectal cancer: Reduces the risk of disease recurrence. - Advanced gastric cancer: Used in combination with fluoropyrimidines to improve treatment outcomes.

Oxaliplans       …  …  … … …  … … …  …